0001683168-24-000240.txt : 20240111 0001683168-24-000240.hdr.sgml : 20240111 20240111193830 ACCESSION NUMBER: 0001683168-24-000240 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240109 FILED AS OF DATE: 20240111 DATE AS OF CHANGE: 20240111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Richieri Richard A. CENTRAL INDEX KEY: 0001976193 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32839 FILM NUMBER: 24530329 MAIL ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Avid Bioservices, Inc. CENTRAL INDEX KEY: 0000704562 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 953698422 STATE OF INCORPORATION: DE FISCAL YEAR END: 0430 BUSINESS ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 BUSINESS PHONE: 714.508.6100 MAIL ADDRESS: STREET 1: 14191 MYFORD ROAD CITY: TUSTIN STATE: CA ZIP: 92780 FORMER COMPANY: FORMER CONFORMED NAME: PEREGRINE PHARMACEUTICALS INC DATE OF NAME CHANGE: 20001109 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE CORP/DE/ DATE OF NAME CHANGE: 19970924 FORMER COMPANY: FORMER CONFORMED NAME: TECHNICLONE INTERNATIONAL CORP DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0508 4 2024-01-09 0 0000704562 Avid Bioservices, Inc. CDMO 0001976193 Richieri Richard A. 14191 MYFORD ROAD TUSTIN CA 92780 0 1 0 0 Chief Operations Officer 0 Common Stock, $0.001 par value 2024-01-09 4 M 0 507 A 24675 D Common Stock, $0.001 par value 2024-01-09 4 M 0 945 A 25620 D Common Stock, $0.001 par value 2024-01-09 4 M 0 1060 A 26680 D Common Stock, $0.001 par value 2024-01-10 4 S 0 1055 6.17 D 25625 D Common Stock, $0.001 par value 2024-01-09 4 M 0 40 A 5109 I By Spouse Common Stock, $0.001 par value 2024-01-09 4 M 0 83 A 5192 I By Spouse Common Stock, $0.001 par value 2024-01-09 4 M 0 132 A 5324 I By Spouse Common Stock, $0.001 par value 2024-01-10 4 S 0 116 6.17 D 5208 I By Spouse Restricted Stock Units 2024-01-09 4 M 0 507 0.0000 D Common Stock 507 33385 D Restricted Stock Units 2024-01-09 4 M 0 945 0.0000 D Common Stock 945 32440 D Restricted Stock Units 2024-01-09 4 M 0 1060 0.0000 D Common Stock 1060 31380 D Restricted Stock Units 2024-01-09 4 M 0 40 0.0000 D Common Stock 40 3262 I By Spouse Restricted Stock Units 2024-01-09 4 M 0 83 0.0000 D Common Stock 83 3179 I By Spouse Restricted Stock Units 2024-01-09 4 M 0 132 0.0000 D Common Stock 132 3047 I By Spouse Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Represents the shares automatically sold by the reporting person and/or the reporting person's spouse pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the RSUs described in footnotes 4, 5 and 6. This sale does not represent a discretionary trade. Represents a weighted average sales price per share. These shares were sold at prices ranging from $6.14 to $6.205. The reporting person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote. RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2021, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2021, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2022, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2022, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. RSUs granted to the reporting person and/or the reporting person's spouse on July 9, 2023, vest in sixteen (16) equal quarterly installments over a four (4) year period beginning October 9, 2023, and each quarter thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. /s/ Stephen Hedberg, by Power of Attorney for Richard A. Richieri 2024-01-11